The Bottom Line GLP-1 medications can be powerful tools for medical weight loss , but long-term success often depends on what happens beyond the prescription itself
J Clin Invest (2019) 129:37327
A Claims-Based Study of 30,458 Patients A retrospective cohort study using insurance claims and electronic health records compared 14,101 bariatric surgery patients (mean follow-up 34 months) against 16,357 GLP-1 patients (mean follow-up 32 months), all with class II or III obesity
It is suitable for all skin types and ideal for daily use
In the AHK-Cu vs GHK-Cu debate, GHK-Cu has the larger body of research behind its potential benefits, while AHK-Cu's research is more specifically focused on hair applications
[28] identified disrupted acyl lipid and steroid metabolism in ME/CFS patients, in contrast to healthy controls